Table 2 Classification of drug RCTs according to sponsor type
From: Recommendations for a uniform assessment of publication bias related to funding source
Non-industry trial | Industry-supported trial | Industry-sponsored trial | ||
|---|---|---|---|---|
1. | Pharmaceutical company explicitly reported as study sponsor in manuscript | X | ||
2. | Company funding the trial participated in design, conduct, analysis, writing of article and/or decision to publish | X | ||
3. | Trial funded by industry and author(s) affiliated to industry, but role of funding source not reported | X | ||
4. | Financial support received from pharmaceutical company | X | ||
5. | Donation of study medication or placebos by manufacturer | X | ||
6. | One or more authors employed by pharmaceutical company manufacturing the test drug | X | ||
7. | Trial supported by nonprofit organisation owned by pharmaceutical company | X | ||
8. | Investigator-initiated post-hoc analysis of single RCT formally sponsored by industry | X | ||
9. | Pharmaceutical industry not in any way involved in trial | X | ||
Formal study sponsor according to ICH-GCP guidelines | Nonprofit organisation | Nonprofit organisation | Pharmaceutical company | |
Responsible party for quality and safety measures during trial | Nonprofit organisation | Nonprofit organisation | Pharmaceutical company | |